Consistent with a role for M2a Mφ in the resolution of DSS-induced colitis, the rosiglitazone-treated TLR4-SNP mice exhibited increased expression of the M2a protein, Ym1 (Chil3), compared to the saline-treated group (Fig. 6F). Here, TLR4 is linked to colitis.